| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |